City of Hope | Strategic Alliance Partners

Latest from City of Hope

Dr. Siddiqi on the Rationale to Evaluate CAR T-Cell Therapy in CLL

December 23, 2020

Video

Tanya Siddiqi, MD, discusses the rationale to evaluate CAR T-cell therapy in chronic lymphocytic leukemia.

Breast Cancer: Chaired by Joanne Mortimer, MD

December 14, 2020

Video

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of breast cancer.

City of Hope doctors lead novel clinical trial to treat cancer patients with COVID-19

October 07, 2020

Article

City of Hope is investigating an innovative treatment for cancer patients with COVID-19 by repurposing leflunomide, an anti-inflammatory drug for rheumatoid arthritis that is inexpensive and has few serious side effects, in a new clinical trial.

Dr. Pal on the Safety Profile of Cabozantinib/Atezolizumab in Advanced RCC

October 01, 2020

Video

Sumanta K. Pal, MD, discusses the safety profile of cabozantinib in combination with atezolizumab in advanced renal cell carcinoma.

City of Hope enters licensing agreement with Chimeric to develop its pioneering chlorotoxin CAR T cell therapy

September 22, 2020

Article

The comprehensive cancer center has also dosed its first patient in chlorotoxin CAR T cell therapy trial.

Dr. Pal on the Rationale for the TIVO-3 Trial With Tivozanib in Advanced RCC

September 15, 2020

Video

Sumanta K. Pal, MD, discusses the rationale behind the phase 3 TIVO-3 trial with tivozanib in advanced renal cell carcinoma.